Gamco Investors INC. ET AL trimmed its stake in Danaher Co. (NYSE:DHR) by 6.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 9,270 shares of the conglomerate’s stock after selling 640 shares during the period. Gamco Investors INC. ET AL’s holdings in Danaher were worth $915,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Private Capital Group LLC lifted its position in Danaher by 445.0% during the 1st quarter. Private Capital Group LLC now owns 1,744 shares of the conglomerate’s stock valued at $171,000 after acquiring an additional 1,424 shares during the period. CIBC Asset Management Inc increased its stake in Danaher by 12.5% during the 2nd quarter. CIBC Asset Management Inc now owns 68,204 shares of the conglomerate’s stock valued at $6,730,000 after purchasing an additional 7,565 shares in the last quarter. Pratt Collard Advisory Partners LLC increased its stake in Danaher by 3.8% during the 2nd quarter. Pratt Collard Advisory Partners LLC now owns 17,586 shares of the conglomerate’s stock valued at $1,735,000 after purchasing an additional 650 shares in the last quarter. People s United Financial Inc. increased its stake in Danaher by 1.5% during the 2nd quarter. People s United Financial Inc. now owns 176,603 shares of the conglomerate’s stock valued at $17,427,000 after purchasing an additional 2,586 shares in the last quarter. Finally, Janney Montgomery Scott LLC increased its stake in Danaher by 3.5% during the 2nd quarter. Janney Montgomery Scott LLC now owns 111,591 shares of the conglomerate’s stock valued at $11,012,000 after purchasing an additional 3,755 shares in the last quarter. 76.95% of the stock is owned by hedge funds and other institutional investors.
In other news, CFO Daniel L. Comas sold 77,407 shares of Danaher stock in a transaction that occurred on Thursday, July 26th. The shares were sold at an average price of $103.93, for a total value of $8,044,909.51. Following the completion of the sale, the chief financial officer now directly owns 135,218 shares in the company, valued at $14,053,206.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP William K. Daniel sold 103,086 shares of Danaher stock in a transaction that occurred on Friday, August 10th. The stock was sold at an average price of $100.63, for a total transaction of $10,373,544.18. Following the completion of the sale, the executive vice president now owns 167,080 shares of the company’s stock, valued at $16,813,260.40. The disclosure for this sale can be found here. Insiders sold 299,961 shares of company stock valued at $30,619,691 over the last quarter. Company insiders own 11.90% of the company’s stock.
A number of analysts have weighed in on DHR shares. Bank of America set a $113.00 price objective on shares of Danaher and gave the company a “buy” rating in a research note on Thursday, July 19th. Royal Bank of Canada raised their price objective on shares of Danaher to $107.00 and gave the company a “positive” rating in a research note on Thursday, July 19th. They noted that the move was a valuation call. Morgan Stanley raised their price objective on shares of Danaher from $113.00 to $120.00 and gave the company an “overweight” rating in a research note on Friday, July 13th. Finally, Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research note on Monday, July 23rd. Two research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Danaher currently has an average rating of “Buy” and an average target price of $108.31.
Shares of DHR stock opened at $104.66 on Friday. Danaher Co. has a 52 week low of $83.81 and a 52 week high of $106.08. The company has a market capitalization of $73.19 billion, a PE ratio of 24.16, a P/E/G ratio of 2.00 and a beta of 1.03. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.50 and a quick ratio of 1.07.
Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 19th. The conglomerate reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The firm had revenue of $4.98 billion during the quarter, compared to analyst estimates of $4.91 billion. During the same period in the previous year, the business posted $0.99 earnings per share. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. equities research analysts anticipate that Danaher Co. will post 4.49 EPS for the current fiscal year.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Featured Article: Understanding Average Daily Trade Volume
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.